Cost analysis of the first line antiretroviral therapy in Russian Federation

Cost analysis of the first line antiretroviral therapy in Russian Federation

Costs of HIV-infection treatment in Russian Federation are a considerable burden on national resources.Study objective: calculation of one year costs for first line antiretroviral therapy (ART) according to Recommendations (clinical guidelines) of Russian Federal/National Research and Methodology Ce...

Full description

Saved in:

Bibliographic Details
Main Author:	A. V. Rudakova
Format:	Article
Language:	Russian
Published:	Journal Infectology 2014-09-01
Series:	Журнал инфектологии
Subjects:	hiv infection therapy guidelines cost analysis
Online Access:	https://journal.niidi.ru/jofin/article/view/224
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS
by: M. B. Kubaeva, et al.
Published: (2017-08-01)

Durability of first-line antiretroviral treatment in the Russian Federation: retrospective study
by: N. V. Sizova, et al.
Published: (2023-10-01)

Comparison of efficacy and safety of antiretroviral first-line therapy with phosphazideortdf
by: A. V. Kravchenko, et al.
Published: (2018-12-01)

Human immunodeficiency virus pretreatment drug resistance to first line antiretroviral therapy: a single center study
by: Hadir Okasha, et al.
Published: (2025-04-01)

Panhypopituitarism in HIV patient receiving antiretroviral therapy
by: Tatyana B. Morgunova, et al.
Published: (2021-12-01)

Evaluation of the Cost-Effectiveness of Vaccination of Children with 5-valent Vaccine against Rotavirus Infection in the Russian Federation
by: Alla V. Rudakova, et al.
Published: (2018-01-01)

IMPROVING ANTIRETROVIRAL THERAPY IN CHILDREN WITH HIV INFECTION
by: V. B. Denisenko, et al.
Published: (2018-07-01)

Pharmacoeconomic analysis of antiretroviral therapy regimes in the Syrian Arab Republic
by: Yu. Sh. Gushchina, et al.
Published: (2023-07-01)

Cost of epilepsy in the Russian Federation
by: A. S. Romanov, et al.
Published: (2024-10-01)

Assessment of efficiency of treatment of patients with acute HIV infection with use in the scheme of antiretroviral therapy elsulfavirin
by: Ya. S. Ulyanova, et al.
Published: (2021-07-01)

FIVE-YEAR EXPERIENCE OF HIGHLY ACTIVITY ANTIRETROVIRAL THERAPY IN CHILDREN WITH HIV-INFECTION
by: V. B. Denisenko, et al.
Published: (2015-09-01)

Antiretroviral Therapy Complications and Their Correction in HIV-Infected Pregnant Women in the Perioperative Period
by: E. M. Shifman, et al.
Published: (2011-06-01)

Сost-effectiveness of pentavalent rotavirus vaccination in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2023-01-01)

Immunological outcomes after six months with first line antiretroviral therapy: a lesson from Yogyakarta, Indonesia
by: Mardy Pangarungan, et al.
Published: (2018-05-01)

Impact of Covid-19 Pandemic Lockdown on Delivery of Antiretroviral Therapy to Persons Living with HIV Infection
by: Akwiwu E.C.*, Akpan P.A., Isong I.K.P., Akpotuzor J.O., Okafor A.O., Abunimye D.A., Etim O.O., Ndem B.N., Edem M.S.
Published: (2020-09-01)

ANALYSIS OF TUBERCULOSIS AND HIV INFECTION MORTALITY IN THE REGIONS OF THE RUSSIAN FEDERATION WITH THE MATRIX USE
by: E. B. Tsybikova, et al.
Published: (2015-12-01)

Cost effectiveness analysis of universal varicella vaccination in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2021-10-01)

Features of kidney affection in the conditions of highly active antiretroviral therapy in patients with HIV/AIDS
by: E.V. Ryabokon, et al.
Published: (2013-08-01)

THE RESULTS OF THE EFFICACY AND SAFETY OF THE NEW RUSSIAN DRUG 6НР IN THE ANTIRETROVIRAL THERAPY REGIMENS OF HIV-INFECTED PATIENTS
by: A. V. Kravchenko, et al.
Published: (2019-03-01)

Treatment efficacy and tuberculosis relapses in HIV infected patients with severe immunosuppression who started antiretroviral therapy
by: E. V. Korzh, et al.
Published: (2020-11-01)

The cost-effectiveness of different diagnostic options of TB among HIV-infected patients
by: V. E. Shumlyanskaya, et al.
Published: (2014-12-01)

THE SAFETY OF TREATMENT OF MULTIPLE DRUG RESISTANT TUBERCULOSIS IN HIV POSITIVE PATIENTS RECEIVING ANTIRETROVIRAL THERAPY
by: S. Yu. Degtyareva, et al.
Published: (2019-04-01)

Antiviral therapy in chronic hepatitis C (G1) in Russia: cost and effectiveness
by: A. V. Rudakova, et al.
Published: (2015-04-01)

Incidence of opportunistic infections and its predictors among HIV/AIDS patients on antiretroviral therapy in Gondar University Comprehensive and Specialized Hospital, Ethiopia
by: Mequanente Dagnaw, et al.
Published: (2023-12-01)

Micro-costing analysis from Italian Guidelines for the management of sporadic primary hyperparathyroidism
by: Ilaria Valentini, et al.
Published: (2025-07-01)

Assessment of reduction of rotavirus infection burden in case of vaccination with a pentavalent vaccine in Russian Federation
by: A. V. Rudakova, et al.
Published: (2014-09-01)

Cost-effectiveness of meningococcal vaccination of infants in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2021-12-01)

HIV Situation in the Penitentiary System of the Russian Federation
by: S. B. Ponomarev, et al.
Published: (2022-04-01)

Adherence and Cost–Utility Analysis of Antiretroviral Treatment in People Living with HIV in a Specialized Clinic in Mexico City
by: Ivo Heyerdahl-Viau, et al.
Published: (2025-05-01)

The influence of genetic factors on the effectiveness, safety and tolerability of antiretroviral therapy in patients with hiv infection
by: V. G. Kanestri, et al.
Published: (2021-03-01)

Metabolic syndrome among people living with HIV on first-line antiretroviral therapy in scarce-resource settings: an evidence from Tanzanian facility-based survey
by: Deogratius Bintabara, et al.
Published: (2025-08-01)

INSTIs-centered antiviral regimens for first-line treatment of HIV/AIDS: a network meta-analysis and cost-effectiveness analysis
by: Jian Yang, et al.
Published: (2025-04-01)

Costs analysis of integrating group interpersonal therapy into HIV care services in Senegal
by: Yao Abounan, et al.
Published: (2025-01-01)

Comparative Cost Analysis of Four Interventions to Prevent HIV Transmission in Bandung, Indonesia
by: Eveline J.M. Verstraaten, et al.
Published: (2017-11-01)

Comparative Cost Analysis of Four Interventions to Prevent HIV Transmission in Bandung, Indonesia
by: Eveline J.M. Verstraaten, et al.
Published: (2017-11-01)

Actual issues of lipid centers’ operation in Russian Federation
by: S. Boytsov, et al.
Published: (2021-02-01)

Health-related quality of life of patients on antiretroviral therapy at the Federal Medical Center, Makurdi, Nigeria
by: Vivian Shaahu, et al.
Published: (2019-07-01)

CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF HIV-INFECTION IN DYNAMICS AGAINST THE BACKGROUND OF ANTIRETROVIRAL THERAPY AMONG PATIENTS IN POLTAVA REGION
by: O.H. Marchenko, et al.
Published: (2019-12-01)

COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION
by: A. V. Rudakova, et al.
Published: (2015-09-01)

COST OF ILLNESS ANALYSIS: TYPES, METHODOLOGY, RUSSIAN SPECIFICS
by: R. I. Yagudina, et al.
Published: (2015-03-01)